Tate & Lyle’s share price soars to 8-year peaks! Here’s what you need to know

Tate & Lyle’s share price has rocketed to its most expensive price since late 2013. Here’s why the FTSE 250 firm has risen today.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

The Tate & Lyle (LSE: TATE) share price has flown higher since the start of 2021. After beginning the year at 634p per share, the food ingredients maker has gained a mammoth 19% in value. It’s up by a similar percentage over the past 12 months too.

Tate & Lyle’s share price soared on Monday as talk of a break-up of the group has emerged. At 803p per share as I write, the FTSE 250 firm is up 6%+ on the day. It touched intraday peaks around 809p earlier in the session, levels not seen since late 2013.

Tate & Lyle looks to split

Today Tate & Lyle updated the market in response to media speculation at the weekend concerning a possible splitting up of the group. In line with those rumours, the company confirmed that it is “in the process of exploring the potential to separate its Food & Beverage Solutions and Primary Products businesses.”

Tate & Lyle said that it was investigating a way to separate these businesses by selling a controlling stake in the Primary Products division to a new long-term financial partner.

The FTSE 250 firm said that it “continues to successfully execute its strategy and remains confident in the future growth prospects of the company.” However, it added that separating Food & Beverage Solutions and Primary Products “would enable Tate & Lyle and the new business to focus their respective strategies and capital allocation priorities and create the opportunity for enhanced shareholder value.”

It noted that discussions with potential new partners in its Primary Products unit “are at an early stage.” It added too that “therefore there can be no certainty that a transaction will be concluded.”

Suitors waiting in the wings?

Today’s statement follows reports yesterday that Tate & Lyle was about to put part of its Primary Products division on the auction block to raise a whopping £1.2bn. The Sunday Telegraph reported that US private equity firms Apollo Global Management and Cerberus have already held talks with the British company over a deal.

The Primary Products arm manufactures artificial sweeteners and industrial starches for customers in the food & beverage industries. The unit generated around 46% of group profits during the six months to September, latest financials showed.

A tasty takeover

It’s perhaps no surprise that Tate & Lyle is seeking to hive off part of its this unit. Operating margins here are much lower than at the company’s other operations. In the half-year to September, margins here clocked in at 9.9%. This compares to readings of 20.5% and 34.9% at the firm’s Food & Beverage Solutions and Sucralose divisions respectively.

The move would also allow Tate & Lyle to eradicate its large debt pile (of £358m as of September). It could also chase further growth opportunities through significant acquisitions like that of Stevia manufacturer Sweet Green Fields in December.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »